Possible Relation of Roseolovirus Infection with Fibromyalgia / Iespējamā Roseolovīrusu Infekcijas Saistība Ar Fibromialīiju

Open access

Abstract

Fibromyalgia (FM) is a chronic widespread pain disorder that impacts 0.5%-7% of the general population worldwide. The aetiology and pathogenesis of the disease are still unknown. Human herpesvirus-6 and -7 belong to the family Herpesviridae, subfamily Betaherpesvirinae, and genus Roseolovirus and are immunomodulating viruses potentially pathogenic to the nervous system. Presence of anti-HHV-6 and -HHV-7 antibodies and viral genomic sequences, viral loads, HHV-6 variant-specificity, and TNF-α level were studied in 41 FM patients and 50 healthy individuals using polymerase chain reactions, restriction endonuclease analysis and ELISA. There was no difference in the presence of anti-HHV-6 and anti-HHV-7 IgG class antibodies between FM patients and control group individuals. Viral sequences were found in 80.5% of FM patients and in 62.0% of controls. Significantly higher rate of concurrent HHV-6 and HHV-7 infection and higher viral loads in peripheral blood were detected in FM patients compared to the control group individuals. Plasma viremia was detected only in FM patients. Significantly higher TNF-α levels were detected in virus positive FM patients. From all positive cases only in two FM patients HHV-6A was revealed. Significantly higher detection frequency of concurrent HHV-6 and HHV-7 infection, simultaneous HHV-6 and HHV-7 activation, higher viral loads and TNF-α expression levels in primary FM patients than in control group individuals indicate the potential involvement of Roseoloviruses in development of this disorder.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Ablashi D. V. Eastman H. B. Owen C. B. Roman M. M. Friedman J. Zabriskie J. B. Peterson D. L. Pearson G. R. Whitman J. E. (2000). Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol. 16 (3) 179-191.

  • Ablashi D. Agut H. Alvarez-Lafuente R. Clark D. A. Dewhurst S. DiLuca D. Flamand L. Frenkel N. Gallo R. Gompels U. A. Höllsberg P. Jacobson S. Luppi M. Lusso P. Malnati M. Medveczky P. Mori Y. Pellett P. E. Pritchett J. C. Yamanishi K. Yoshikawa T. (2014). Classification of HHV-6A and HHV-6B as distinct viruses. Arch. Virol. 159 (5) 863-870.

  • Albin J. Neumann L. Buskila D. (2008). Pathogenesis of fibromyalgia: A review. Joint Bone Spine 75 273-279.

  • Atedzoe B. N. Menezes J. DAddario M. Xu J. Ongradi J. Ahmad A. (1999). Modulatory effects of HHV-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures. J. Leukoc. Biol. 66 (5) 822-828.

  • Ballantyne J. C. Cousins M. J. Gimberardino M. A. McGrath P. A. Rajagopal M. R. Smith M. T. Sommer C. Wittink H. M. (2010). Fibromyalgia: A clinical update. Pain. Clinical Updates 18 (4).

  • Balon R. Wise T. N. (eds.) (2015). Clinical challenges in the biopsychosocial interface. Update on Psychosomatics for the 21st Century. Adv. Psychosom. Med. 34 78-91.

  • Bansal A. S. Bradley A. S. Bishop K. N. Kiani-Alikhan S. Ford B. (2012). Chronic fatigue syndrome the immune system and viral infection. Brain Behav. Immun. 26 (1) 24-31.

  • Bates M. Monze M. Bima. H. Kapambw M. Clark D. Kasolo F. C. Gompels U. A. (2009). Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. J. Med Virol. 81 (3) 779-789.

  • Berneman Z. N. Ablashi D. V. Li G. Eger-Fletcher M. Reitz M. S. Hung C. L. Brus I. Komaroff A. L. Gallo R. C. (1992). Human herpesvirus 7 is a T-lymphotropic virus and is related to but significantly different from human herpesvirus 6 and human cytomegalovirus. Proc. Natl. Acad. Sci. USA 89 (21) 10552-10556.

  • Bhanushali M. J. Kranick S. M. Freeman A. F. Cuellar-Rodriguez J. M. Battiwalla M. Gea-Banacloche J. C. Hickstein D. D. Fahle G. Nath A. (2013). Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation. Neurology 80 (16) 1494-1500.

  • Borchers A. T. Gershwin M. E. (2015). Fibromyalgia: a critical and comprehensive review. Clin. Rev. Allergy Immunol. 49 (2) 100-151.

  • Boutolleau D. Duros C. Bonnafous P. Caiola D. Karras A. Castro N. D. Ouachee M. Narcy P. Gueudin M. Agut H. Gautheret-Dejean (2006). Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J. Clin. Virol. 35 (5) 257-263.

  • Boutolleau D. Fernandez C. Andre E. Imbert-Marcille B. M. Milpied N. Agut H Gautheret-Dejean A. (2003). Human herpesvirus (HHV)-6 and HHV-7: Two closely viruses with different infection profiles in stem cell transplantation recipients. J. Infect. Dis. 187 (2) 179-186.

  • Branco J. C. Bannwarth B. Failde I. Abello Carbonell J. Blotman F. Spaeth M. Saraiva F. Nacci F. Thomas E. Caubère J. P. Le Lay K. Taieb C. Matucci-Cerinic M. (2010). Prevalence of fibromyalgia: A survey in five European countries. Semin. Arthritis Rheum. 39 (6) 448-453.

  • Buchwald D. Goldenberg D. L. Sullivan J. L. Komaroff A. L. (1987). The “chronic active Epstein-Barr virus infection” syndrome and primary fibromyalgia. Arthritis Rheum. 30 (10) 1132-1136.

  • Cassisi G. Sarzi-Puttini P. Cazzola M. (2011). Chronic widespread pain and fibromyalgia: Could be some relationships with infections and vaccinations? Clin. Exp. Rheumatol.. 29 (6 Suppl. 69) 118-126.

  • Chan P. K. Ng H. K. Hui M. Cheng A. F. (2001). Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J. Med. Virol. 64 (1) 42-46.

  • Chapenko S. Folkmane I. Ziedina I. Chistyakovs M. Rozentals R. Krumina A. Murovska M. (2009). Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy. J. Clin. Virol. 46 (1) 29-32.

  • Chapenko S. Krumina A. Logina I. Rasa S. Chistjakovs M. Sultanova A. Viksna L. Murovska M. (2012). Association of active human herpesvirus-6 -7 and parvovirus B19 with clinical outcomes in patients with mialgic encephalomyelitis/chronic fatigue syndrome. Adv. Virol. 205085.

  • Chapenko S. Krumina A. Kozireva S. Nora Z. Sultanova A. Viksna L. Murovska M. (2006). Activation of human herpesvirus 6 and 7 in patients with chronic fatigue syndrome. J. Clin. Virol. (Suppl.1) 147-151.

  • Chapenko S. Millers A. Nora Z. Logina I. Kukaine R. Murovska M. (2003). Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J. Med. Virol. 69 (1) 111-117.

  • Clauw D. J. Arnold L. M. McCarbero B. H. (2011). The science of fibromyalgia. Mayo Clin. Proc. 86 (9) 907-911.

  • Donati D. Akhyani N. Fogdell-Hahn A. Cermelli C. Cassiani-Ingoni R. Vortmeyer A. Heiss J. D. Cogen P. Gaillard W. D. Sato S. Theodore W. H. Jacobson S. (2003). Detection of HHV-6 in mesial lobe epilepsy surgical brain resections. Neurology 61 (10) 1405-1411.

  • Fotheringham J. Donati D. Akhyani N. Fogdell-Hahn A. Vortmeyer A. Heiss J. D. Williams E. Weinstein S. Bruce D. A. Gaillard W. D. Sato S. Theodore W. H. Jacobsons S. (2007). Association of human herpesvirus-6B with mesial temporal lobe epilepsia. PloS Med. 4 e180.

  • Fox C. Walker-Bone K. (2015). Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract. Res. Clin. Rheumatol. 29 (2) 244-258.

  • Goldberg D. L. (1989). Fibromyalgia and its relation to chronic fatigue syndrome viral illness and immune abnormalities. J. Rheum. 16 (suppl 19) 91-93.

  • Hakim A. J. Keer R. Grahame R. W. (2010). Hypermobility Fibromyalgia and Chronic Pain. Churchill Livingstone Elsevier London. 310 pp.

  • Hall C. B. Caserta M. T. Schnabel K. C. McDermott M. P. Lofthus G. K. Carnahan J. A. Gilbert L. M. Dewhurst S. (2006). Characteristic and acquisition of human herpesvirus (HHV-7) infections in relation to infection with HHV-6. J. Infect. Dis. 193 (8) 1063-1069.

  • Jiao J. Vincent A. Cha S. S. Luedtke C. A. Oh T. H. (2014). Relation of age with symptom severity and quality of life in patients with fibromyalgia. Mayo Clin. Proc. 8 (2) 199-206.

  • Katsafanas G. S. Schirmer E. C. Wyatt L. S. Frenke N. (1996). In vitro activation of human herpesvirus 6 and 7 from latency. Proc. Natl. Acad. Sci USA 93 (18) 9788-9792.

  • Kole A. K. Roy R. Kole D. C. (2013). Musculoskeletal and rheumatologic disorders in HIV infection: Experience in tertiary referral center. Indian. J. Sex Transm. Dis. 34 (2) 107-112.

  • Kozanoglu E. Canataroglu A. Abayli B. Colakoglu S. Goncu K. (2003). Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol. Int. 23 (5) 248-251.

  • Lusso P. (2006). HHV-6 and immune system: Mechanisms of immunomodulation and viral escape. J. Clin. Virol. 37 (Suppl 1) 4-10.

  • Massih R. C. A. Razonable R. R. (2009). Human herpesvirus 6 infection after liver transplantation. World J. Gastroenterol. 15 2561-2569.

  • Menzies V. Lyon D. (2010). Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms. Biol. Res. Nurs. 11 (4) 387-394.

  • Mohammad A. Carey J. J. Storan E. Scarry M. Coughlan R. J. Lee J. M. (2012). Prevalence of fibromyalgia among patients with chronic hepatitis C infection: Relationship to viral characteristics and quality of life. J. Clin. Gastroenterol. 46 (5) 407-412.

  • Niehusmann P. Mittelstaedt T. Bien C. G. Drexler J. F. Grote A. Schoch S. Becker A. (2010). Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia 51 (12) 2478-2483.

  • Nora-Krukle Z. Chapenko S. Logina I. Millers A. Platkajis A. Murovska M. (2011). Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas) 47 527-531.

  • Rogal S. S. Bielefeldt K. Wasan A. D. Szigethy E. Lotrich F. DiMartini A. F. Fibromyalgia symptoms and cirrhosis. Dig. Dis. Sci. 2015 60 (5) 1482-1489.

  • Secchiero P. Carrigan D. R. Asano Y. Benedetti L. Crowley R. W. Komaroff A. L. Gallo R. C. Lusso P. (1995). Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J. Infect. Dis. 171 (2) 273-280.

  • Smith H. S. Harris R. Clauw D. (2011). Fibromyalgia: An afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician 14 (2) E217-245.

  • Sprott H. (2011). Is a fibromyalgia a viral disease? J. Rheumatol. 70 (8) 637-638.

  • Staud R. (2011). Brain imaging in fibromyalgia syndrome. Clin. Exp. Rheumatol. 29 (6 Suppl 69) 109-117.

  • Tanaka-Taya K. Kondo T. Nakagawa N. Inagi R. Miyoshi H. Sunagawa T. Okada S. Yamanishi K. (2000). Reactivation of human herpesvirus 6 by infection of human herpesvirus 7. J. Med. Virol. 60 (3) 284-289.

  • Wife P. J. Derry S. Moore A. R. (2013). Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev. 12 CD006044.

  • Wolfe F. Clauw D. J. Fitzcharles M. A. Goldenberg D. L. Hauser W. Katz R. S. Mease P. Russell A. S. Russell I. J. Winfield J. B. (2011). Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 38 (6) 1113-1122.

  • Yao K. Crawford J. R. Komaroff A. L. Ablashi D. V. Jacobson S. (2010). Review part 2: Human herpesvirus-6 in central nervous system diseases. J. Med. Virol. 82 (10) 1669-1678.

  • Yoshikawa T. Asano Y. (2000). Central nervous system complications in human herpesvirus 6 infection. Brain Dev. 22 (5) 307-314.

Search
Journal information
Impact Factor


CiteScore 2018: 0.3

SCImago Journal Rank (SJR) 2018: 0.137
Source Normalized Impact per Paper (SNIP) 2018: 0.192

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 218 100 3
PDF Downloads 99 62 0